J&J Antacid Recall Announced

MylantaJohnson & Johnson has added additional products to its list of recalls for this year: twelve types of Mylanta and one Alternagel antacid. The wholesale and retail level recall, which affects as many as 12 million bottles of Mylanta and 85,000 bottles of Alternagel, was not initiated because of consumer safety concerns, Johnson & Johnson explained, but because an internal review within the company showed that the bottles had failed to make note of the alcohol content in some flavoring agents.

“Certain flavoring agents contribute small (less than 1 percent) amounts of alcohol,” J&J explained on the Mylanta website. “It is unlikely that use of these products will cause either absorption or alcohol sensitivity related adverse events.”

The health care product company has already instituted more than six recalls this year, most notably the April 30 recall of over forty types of children’s pain and allergy medications, which included children’s liquid Tylenol, Benadryl, and Motrin. The FDA termed that recall the “largest” in children’s medicine history.